Friday
Options
Unusual total active…
Unusual total active option classes on open include: Powershares Loan ETF (BKLN), Nordstrom (JWN), ProShares UltraShort DJ-UBS Natural Gas (KOLD), Albemarle (ALB), AT&T (T), C3 AI (AI), iShares Silver Trust (SLV), Bausch Health (BHC), Barrick Gold (GOLD), and Meta Platforms (Facebook) (META).
Show Hide Related Items >> <<
01/25/23 AT&T says outlook 'conservative' given economic uncertainty 01/25/23 AT&T says ARPU growth continuing to come in ahead of expectations 01/25/23 AT&T expects 'challenging' macroeconomic environment near term 01/25/23 AT&T expects profit growth to continue in 2023 02/01/23 Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B 02/01/23 Meta says 2023 will be 'a year of efficiency' 02/01/23 Meta Platforms announces $40B increase in share repurchase authorization 02/01/23 Meta Platforms reports FoA and RL segment restructuring charges KOLD ProShares UltraShort Bloomberg Natural Gas 02/01/23 ProShares UltraShort Bloomberg Natural Gas rises 15.6% 01/30/23 ProShares UltraShort Bloomberg Natural Gas rises 10.6% 01/30/23 ProShares UltraShort Bloomberg Natural Gas rises 10.8% 01/26/23 ProShares UltraShort Bloomberg Natural Gas rises 9.3% 02/02/23 Nordstrom ends afterhours session up 31% after WSJ report on Ryan Cohen stake 01/25/23 Nordstrom Default Rating downgraded to junk by Fitch 01/19/23 Nordstrom falls 7% to $16.27 after cutting FY22 outlook 01/19/23 Nordstrom cuts FY22 EBIT margin view to 2.8%-3.1% from 4.1%-4.4% 02/01/23 Barrick Gold hosts North Mara site visit for human rights NGO 01/31/23 Barrick Gold makes initial $3M payment to Balochistan government for Reko Diq 01/25/23 Barrick Gold says Tanzania gold mines produce 547,000 ounces in 2022 01/17/23 Barrick Gold reports preliminary Q4 gold production 1% lower than 4.2M ozs 12/22/22 Bausch Health' acne lotion included in drug plans of four Canadian provinces 12/16/22 Bausch Health falls -8.5% 12/02/22 Bausch Health wins Bryhali, Duobrii patent infringement case 12/02/22 Bausch Health wins DUOBRII, BRYHALI patent infringement case 01/30/23 Albemarle launches Ketjen, a wholly owned subsidiary 12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 01/31/23 C3.ai rises 25.2% 01/31/23 C3.ai rises 18.8% 01/31/23 C3.ai rises 12.6% 01/27/23 C3.ai rises 14.4% BKLN Invesco Senior Loan ETF 02/03/23 William Blair Nordstrom performance 'begs for an activist role,' says William Blair 02/03/23 Gordon Haskett Nordstrom upgraded to Hold from Reduce at Gordon Haskett 01/30/23 Goldman Sachs Nordstrom initiated with a Neutral at Goldman Sachs 01/20/23 Deutsche Bank Nordstrom price target lowered to $17 from $21 at Deutsche Bank KOLD ProShares UltraShort Bloomberg Natural Gas 01/31/23 Credit Suisse Albemarle price target raised to $240 from $200 at Credit Suisse 01/26/23 Mizuho Albemarle price target raised to $325 from $300 at Mizuho 01/26/23 Piper Sandler Albemarle initiated with Overweight, $310 target at Piper Sandler 01/25/23 Piper Sandler Albemarle initiated with an Overweight at Piper Sandler 01/26/23 Cowen AT&T price target raised to $25 from $24 at Cowen 01/24/23 Citi AT&T price target raised to $22 from $20 at Citi 01/13/23 Truist American Tower price target lowered to $275 from $325 at Truist 01/10/23 Citi Citi adds AT&T, Equinix to 'Positive Catalyst Watch List' 02/02/23 DA Davidson C3.ai initiated with a Buy at DA Davidson 12/08/22 Morgan Stanley C3.ai price target lowered to $12 from $13 at Morgan Stanley 12/08/22 Piper Sandler C3.ai price target lowered to $13 from $14 at Piper Sandler 12/08/22 Deutsche Bank C3.ai price target lowered to $11 from $13 at Deutsche Bank 11/18/22 BofA Generic guidance for Bausch Health's Xifaxan 'not a surprise,' says BofA 11/17/22 Evercore ISI FDA made 'key change' to guidance on generic Xifaxan, says Evercore ISI 10/20/22 Jefferies Bausch Health assumed with a Hold at Jefferies 09/09/22 Piper Sandler Bausch Health price target lowered to $6 from $7 at Piper Sandler 01/30/23 Barclays Barrick Gold price target raised to $26 from $23 at Barclays 01/13/23 National Bank Barrick Gold price target raised to C$30 from C$25 at National Bank 11/29/22 National Bank Barrick Gold price target raised to C$25 from C$24 at National Bank 11/21/22 RBC Capital Barrick Gold price target lowered to $20 from $27 at RBC Capital 02/03/23 DA Davidson Amazon.com price target raised to $134 from $114 at DA Davidson 02/03/23 HSBC Meta Platforms downgraded to Reduce from Hold at HSBC 02/03/23 DZ Bank Meta Platforms upgraded to Hold from Sell at DZ Bank 02/02/23 Deutsche Bank Meta Platforms price target raised to $200 from $125 at Deutsche Bank 01/25/23 AT&T sees FY23 adjusted EPS $2.35-$2.45, consensus $2.56 01/25/23 AT&T reports Q4 adjusted EPS 61c, consensus 57c 01/24/23 Notable companies reporting before tomorrow's open 02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 11/22/22 Nordstrom backs FY22 adjusted EPS view $2.30-$2.60, consensus $2.34 11/22/22 Nordstrom reports Q3 adjusted EPS 20c, consensus 14c 11/22/22 Notable companies reporting after market close 11/03/22 Barrick Gold reports Q3 adjusted EPS 13c, consensus 31c 08/08/22 Barrick Gold reports Q2 adjusted EPS 24c, consensus 31c 11/03/22 Bausch Health cuts FY22 revenue view to $8.0B-$8.17B from $8.05B-$8.22B 11/03/22 Bausch Health reports Q3 adjusted EBITDA $766M vs. $885M y/y 08/09/22 Bausch Health lowers FY22 revenue view to $8.05B-$8.22B from $8.25B-$8.40B 08/09/22 Bausch Health reports Q2 GAAP EPS (40c), consensus 89c 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 12/07/22 C3.ai backs FY23 revenue view of $255M-$270M, consensus $260.8M 12/07/22 C3.ai sees Q3 revenue $63.0M-$65.0M, consensus $66.8M 12/07/22 C3.ai reports Q2 EPS (11c), consensus (16c) 08/31/22 C3.ai cuts FY23 revenue view to $255M-$270M from $308M-$316M 01/12/23 DirecTV lays off hundreds of employees, Deadline reports 12/26/22 AT&T to build broadband services outside its current markets, WSJ reports 12/20/22 YouTube discussed paying $2.5B a year for NFL Sunday Ticket games, NYT says 12/20/22 FCC partisan deadlock shields wireless companies from $200M fine, WSJ reports 02/02/23 FTC denies Meta request to bar Khan from antitrust case, Bloomberg says 02/01/23 GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports 02/01/23 Meta wins approval over FTC to acquire Within Unlimited, Bloomberg says 02/01/23 Meta debates on whether to share Reel money with creators, Information reports 02/02/23 Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports 09/20/22 Nordstrom 'back on takeover target list' after poison pill filing 10/15/22 BHP among mining stocks with bright long-term outlook, Barron's says 08/22/22 Bausch Health taps advisers to help it map out future, WSJ reports 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 02/02/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/23 Fly Intel: Pre-market Movers 01/30/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/20/23 What You Missed On Wall Street This Morning 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 What You Missed On Wall Street On Thursday 12/08/22 What You Missed On Wall Street This Morning 09/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/01/22 Fly Intel: Pre-market Movers 01/25/23 Early notable gainers among liquid option names on January 25th 01/17/23 AT&T call volume above normal and directionally bullish 01/09/23 Unusually active option classes on open January 9th 01/04/23 Unusually active option classes on open January 4th 01/23/23 Unusually active option classes on open January 23rd 12/22/22 Unusually active option classes on open December 22nd 09/19/22 Unusually active option classes on open September 19th 09/12/22 Unusually active option classes on open September 12th 02/03/23 Notable open interest changes for February 3rd 02/03/23 Unusual call flow in option market yesterday 02/02/23 Earnings season driving record option volume 02/02/23 Early notable gainers among liquid option names on February 2nd KOLD ProShares UltraShort Bloomberg Natural Gas 01/26/23 Unusually active option classes on open January 26th 01/20/23 Largest borrow rate increases among liquid names 01/12/23 Largest borrow rate increases among liquid names 01/03/23 Unusually active option classes on open January 3rd 02/01/23 Unusually active option classes on open February 1st 01/27/23 Unusually active option classes on open January 27th 01/20/23 Unusually active option classes on open January 20th 01/05/23 Nordstrom call volume above normal and directionally bullish 01/19/23 Barrick Gold call volume above normal and directionally bullish 12/27/22 Barrick Gold call volume above normal and directionally bullish 12/13/22 Unusually active option classes on open December 13th 12/07/22 Barrick Gold call volume above normal and directionally bullish BKLN Invesco Senior Loan ETF 01/25/23 Largest borrow rate increases among liquid names 11/29/22 Unusually active option classes on open November 29th 10/19/22 Largest borrow rate increases among liquid names 10/18/22 Largest borrow rate increases among liquid names 01/25/23 Bausch Health put volume heavy and directionally bearish 01/20/23 Bausch Health put volume heavy and directionally bearish 01/18/23 Bausch Health put volume heavy and directionally bearish 01/09/23 Bausch Health call volume above normal and directionally bullish 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish 02/02/23 Unusually active option classes on open February 2nd 01/31/23 C3 AI call volume above normal and directionally bullish 01/31/23 Unusually active option classes on open January 31st
Over a week ago
Recommendations
Credit Suisse analyst…
Credit Suisse analyst John Roberts raised the firm's price target on Albemarle to $240 from $200 and keeps an Underperform rating on the shares. The firm cites uncertain lithium pricing but solid volume growth outlook.
Show Hide Related Items >> <<
01/30/23 Albemarle launches Ketjen, a wholly owned subsidiary 12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 01/26/23 Mizuho Albemarle price target raised to $325 from $300 at Mizuho 01/26/23 Piper Sandler Albemarle initiated with Overweight, $310 target at Piper Sandler 01/25/23 Piper Sandler Albemarle initiated with an Overweight at Piper Sandler 01/25/23 Deutsche Bank Albemarle price target raised to $305 from $290 at Deutsche Bank 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Hot Stocks
Albemarle announced the…
Albemarle announced the official brand launch of Ketjen, its wholly owned subsidiary that crafts tailored, advanced catalyst solutions for the petrochemical, refining and specialty chemicals industries. The company shared the new name of its catalysts business in November 2022 after announcing plans to operate the business as a subsidiary. Headquartered in Houston, Texas, Ketjen will collaborate with customers in the petrochemical, refining and specialty chemical industries across three divisions, Fluidized Catalytic Cracking, Clean Fuels and Hydroprocessing Catalysts, and Performance Catalyst & Curative Solutions. Albemarle's existing advanced catalyst solutions team will lead Ketjen operations.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/26/23 Mizuho Albemarle price target raised to $325 from $300 at Mizuho 01/26/23 Piper Sandler Albemarle initiated with Overweight, $310 target at Piper Sandler 01/25/23 Piper Sandler Albemarle initiated with an Overweight at Piper Sandler 01/25/23 Deutsche Bank Albemarle price target raised to $305 from $290 at Deutsche Bank 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Recommendations
Mizuho analyst…
Mizuho analyst Christopher Parkinson raised the firm's price target on Albemarle to $325 from $300 and keeps a Neutral rating on the shares. The analyst left the company's strategic update more constructive on 2023 estimates. The firm is still bullish on intermediate-term demand, but sees Albemarle putting forth a higher bar verses what it anticipated into the event.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/26/23 Piper Sandler Albemarle initiated with Overweight, $310 target at Piper Sandler 01/25/23 Piper Sandler Albemarle initiated with an Overweight at Piper Sandler 01/25/23 Deutsche Bank Albemarle price target raised to $305 from $290 at Deutsche Bank 01/25/23 RBC Capital Albemarle price target raised to $362 from $340 at RBC Capital 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Initiation
Piper Sandler analyst…
Piper Sandler analyst Charles Neivert last night initiated coverage of Albemarle with an Overweight rating and $310 price target. The analyst believes the company is transitioning from a cyclical to one more associated with growth, which deserves a multiple more in line with its historical performance. Albemarle is basically a lithium pure play on a going forward basis, the analyst tells investors in a research note. Not only is lithium a vast proportion of the overall earnings of Albemarle, but it also represents the bulk of the earnings upside, says Piper.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/25/23 Piper Sandler Albemarle initiated with an Overweight at Piper Sandler 01/25/23 Deutsche Bank Albemarle price target raised to $305 from $290 at Deutsche Bank 01/25/23 RBC Capital Albemarle price target raised to $362 from $340 at RBC Capital 01/25/23 Oppenheimer Albemarle price target raised to $497 from $461 at Oppenheimer 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Initiation
Piper Sandler analyst…
Piper Sandler analyst Charles Neivert initiated coverage of Albemarle with an Overweight rating and $310 price target.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/25/23 Deutsche Bank Albemarle price target raised to $305 from $290 at Deutsche Bank 01/25/23 RBC Capital Albemarle price target raised to $362 from $340 at RBC Capital 01/25/23 Oppenheimer Albemarle price target raised to $497 from $461 at Oppenheimer 01/25/23 Baird Albemarle price target raised to $305 from $298 at Baird 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Recommendations
Deutsche Bank analyst…
Deutsche Bank analyst David Begleiter raised the firm's price target on Albemarle to $305 from $290 and keeps a Buy rating on the shares. The analyst says the company had a strong 2023 strategic update with EBITDA guidance 4% ahead of consensus.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/25/23 RBC Capital Albemarle price target raised to $362 from $340 at RBC Capital 01/25/23 Oppenheimer Albemarle price target raised to $497 from $461 at Oppenheimer 01/25/23 Baird Albemarle price target raised to $305 from $298 at Baird 01/24/23 Loop Capital Albemarle strategic update 'very constructive', says Loop Capital 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Recommendations
RBC Capital analyst Arun…
RBC Capital analyst Arun Viswanathan raised the firm's price target on Albemarle to $362 from $340 and keeps an Outperform rating on the shares after its Q4 pre-announcement and medium-term sales growth update. The analyst is positive on the company's growth prospects but cautious on near-term volatility in lithium prices given its exposure to index-based prices and potential demand headwinds from macro weakness. The firm adds however that longer-term, Albemarle is well positioned to serve the EV and sustainable energy high-growth markets.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/25/23 Oppenheimer Albemarle price target raised to $497 from $461 at Oppenheimer 01/25/23 Baird Albemarle price target raised to $305 from $298 at Baird 01/24/23 Loop Capital Albemarle strategic update 'very constructive', says Loop Capital 01/17/23 Deutsche Bank Albemarle named short-term buy idea at Deutsche Bank 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Recommendations
Oppenheimer analyst Colin…
Oppenheimer analyst Colin Rusch raised the firm's price target on Albemarle to $497 from $461 and keeps an Outperform rating on the shares after the company provided an update on its strategic outlook. The firm notes that despite some lithium inventory build in China in Q1 2023, demand for the balance of the year and through the end of the decade appears to be in excess of supply. Oppenheimer views Albemarle as a leader in lithium quality, and points out that the company is growing sustainably at scale as it ramps while continuing to be free cash flow positive.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/25/23 Baird Albemarle price target raised to $305 from $298 at Baird 01/24/23 Loop Capital Albemarle strategic update 'very constructive', says Loop Capital 01/17/23 Deutsche Bank Albemarle named short-term buy idea at Deutsche Bank 01/10/23 Deutsche Bank Albemarle price target lowered to $290 from $325 at Deutsche Bank 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish
Recommendations
Baird analyst Ben Kallo…
Baird analyst Ben Kallo raised the firm's price target on Albemarle to $305 from $298 and keeps a Neutral rating on the shares. The analyst said strong 2022 results and a favorable five-year outlook are driven by continued high demand for EV inputs which are expected to uphold lithium prices in the near term.
Show Hide Related Items >> <<
12/13/22 Albemarle to invest at least $180M in technology park for advanced lithium 11/15/22 Albemarle names Sean O'Hollaren as chief external affairs officer 10/31/22 Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed 10/19/22 Albemarle announces DOE grant for North Carolina lithium facility 01/24/23 Loop Capital Albemarle strategic update 'very constructive', says Loop Capital 01/17/23 Deutsche Bank Albemarle named short-term buy idea at Deutsche Bank 01/10/23 Deutsche Bank Albemarle price target lowered to $290 from $325 at Deutsche Bank 01/04/23 Vertical Research Albemarle upgraded to Buy from Hold at Vertical Research 01/23/23 Albemarle targets 5-year net sales CAGR 19%-21% by 2027 01/23/23 Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03 01/23/23 Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66 01/23/23 Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08 10/31/22 EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says 10/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/27/22 Albemarle call volume above normal and directionally bullish 12/06/22 Albemarle call volume above normal and directionally bullish 11/25/22 Unusually active option classes on open November 25th 11/15/22 Albemarle put volume heavy and directionally bearish